🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
307,02 USD
Máx. histórico
322,75
3 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-4,87%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-4,87%
Cierre anterior
322,75
Rango de hoy
306,17 – 324,95
Volumen hoy
265.433
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 32,35 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/11/2025 | 201,65 | 207,32 | 200,82 | 201,35 | +0,24% | 3,22% | 233.300 |
| 14/11/2025 | 198,93 | 205,32 | 198,52 | 200,86 | -0,20% | 3,42% | 132.300 |
| 13/11/2025 | 203,76 | 208,33 | 198,72 | 201,27 | -2,11% | 4,72% | 220.500 |
| 12/11/2025 | 208,38 | 209,99 | 201,54 | 205,61 | -1,48% | 4,06% | 229.800 |
| 11/11/2025 | 209,29 | 212,49 | 206,54 | 208,70 | -0,28% | 2,84% | 225.500 |
| 10/11/2025 | 204,44 | 209,30 | 201,50 | 209,29 | +3,36% | 3,82% | 279.200 |
| 07/11/2025 | 205,45 | 207,25 | 201,87 | 202,48 | -2,76% | 2,62% | 209.200 |
| 06/11/2025 | 196,00 | 211,92 | 186,96 | 208,22 | +9,37% | 12,73% | 471.800 |
| 05/11/2025 | 189,00 | 193,07 | 187,91 | 190,38 | +0,49% | 2,73% | 210.700 |
| 04/11/2025 | 188,20 | 191,46 | 186,28 | 189,45 | -0,94% | 2,75% | 249.400 |
| 03/11/2025 | 192,97 | 193,02 | 183,91 | 191,24 | -0,04% | 4,72% | 269.500 |
| 31/10/2025 | 187,78 | 192,83 | 186,45 | 191,31 | +2,27% | 3,40% | 383.100 |
| 30/10/2025 | 184,44 | 188,77 | 184,44 | 187,06 | +1,38% | 2,35% | 104.300 |
| 29/10/2025 | 187,80 | 191,88 | 182,87 | 184,52 | -2,30% | 4,80% | 172.800 |
| 28/10/2025 | 189,05 | 194,44 | 187,97 | 188,87 | -0,58% | 3,42% | 259.400 |
| 27/10/2025 | 187,12 | 191,03 | 187,12 | 189,97 | +1,60% | 2,09% | 71.700 |
| 24/10/2025 | 187,11 | 189,60 | 186,22 | 186,98 | +0,93% | 1,81% | 57.900 |
| 23/10/2025 | 185,46 | 186,24 | 183,59 | 185,25 | -0,17% | 1,43% | 57.700 |
| 22/10/2025 | 186,37 | 187,81 | 180,59 | 185,57 | -0,58% | 3,87% | 182.800 |
| 21/10/2025 | 186,00 | 187,30 | 179,00 | 186,66 | -0,04% | 4,46% | 135.400 |
| 20/10/2025 | 182,23 | 187,76 | 181,49 | 186,74 | +2,80% | 3,44% | 117.400 |
| 17/10/2025 | 179,86 | 184,47 | 179,86 | 181,65 | +0,49% | 2,56% | 156.800 |
| 16/10/2025 | 184,18 | 186,48 | 178,34 | 180,77 | -1,38% | 4,42% | 150.300 |
| 15/10/2025 | 181,26 | 185,70 | 178,68 | 183,30 | +1,32% | 3,87% | 108.300 |
| 14/10/2025 | 179,28 | 182,13 | 177,76 | 180,92 | +0,57% | 2,44% | 84.200 |
| 13/10/2025 | 178,68 | 181,35 | 177,85 | 179,89 | +1,22% | 1,96% | 73.600 |
| 10/10/2025 | 181,66 | 182,12 | 177,35 | 177,73 | -2,52% | 2,63% | 115.500 |
| 09/10/2025 | 183,14 | 185,07 | 181,94 | 182,32 | -1,18% | 1,71% | 72.400 |
| 08/10/2025 | 184,47 | 186,40 | 182,52 | 184,49 | +0,73% | 2,10% | 124.500 |
| 07/10/2025 | 183,76 | 183,76 | 179,40 | 183,16 | +0,30% | 2,37% | 98.000 |